entertainment -WSS

entertainment

author：knowledge 2025-10-02 10:38:49 - browse：319

Biogen, a biotech giant plagued by years of boardroom strife, said late Monday that the longtime and polarizing director Alex Denner would step down from its board, sending a signal to investors that the company’s fractious recent history might be coming to a close.

What Biogen didn’t disclose is that its nominee to replace Denner on the board, Susan Langer, is Denner’s live-in romantic partner and the mother of his child, born in November, according to court records obtained by STAT. Denner is in the middle of a protracted divorce from his wife of nearly 25 years, with whom he has two teenage sons — a bitter legal fight in which his extramarital relationship with Langer is a contentious issue, according to the records.

Biogen spokesperson Jack Cox said the company knew about the relationship between Denner and Langer. He also said that Denner recommended Langer to Biogen’s board — he said he incorrectly stated at first that Denner nominated her — but declined to comment on the company’s vetting process and whether it planned to disclose the relationship to shareholders before they vote on Langer’s candidacy later this month. Biogen also omitted mention of the relationship from Langer’s biography in a Securities and Exchange Commission filing Tuesday morning.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Companies helping big Covid

WSS

Women's World Cup brings attention to abuse in soccer

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

How a symptom of dementia informs our understanding of creativity

Antibody drugs appear effective. Now can we make enough of them?

Complete sequence of Y chromosome published for first time

What do new weight loss drugs mean for bariatric surgery?

focus

entertainment

focus

Apple is now the first public company to be valued at $3 trillion

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Drug repurposing or repositioning? The language matters

As pharma fights Medicare drug negotiation, hospitals, docs silent

At least 13 dead in Texas as scorching temps continue

How Long Island became the ‘eugenics capital of the world’

Peter Hotez and the public health issue of online harassment

What AAP's gender

Dobbs anniversary: the lost opportunity of abortion as health care

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

explore

Women's World Cup brings attention to abuse in soccer

Diversity in medical illustrations gets boost from Chidiebere Ibe

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Sickle cell gene therapy cures need to be accessible in Africa

2024 GOP presidential candidates spar over abortion in debate

hotspot

explore

Wikipedia

focus